Remix Therapeutics, a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, announced the appointment of...
Frontage Holdings Corporation ("Frontage") is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer ("CFO"), effective February 1, 2024. As CFO,...
North Memorial Health's Board of Trustees has named Trevor Sawallish as its Chief Executive Officer, effective February 9, 2024. Sawallish has more than 20 years of experience...
RTI Surgical, an industry leading contract development and manufacturing organization (CDMO), serving the regenerative medicine industry, announced that it has completed its previously announced...
Comtech, announced it received approval from the U.S. Army Contracting Command to move forward on the Company’s previously announced $544 million Global Field Service Representative...
